Form 4 · Filed Jun 22, 2026, 08:11 PM UTC
RIGL/RIGEL PHARMACEUTICALS INC
Rojkjaer Lisa — EVP, Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | A | other | 9,375 | — | — | 9,375 |
| Jun 17, 2026 | A | other | 7,394 | — | — | 7,394 |
Source: SEC EDGAR raw filing ↗ · Accession 0000905148-26-003040